[Insulin resistance: why is it important to treat?].

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Diabetes & Metabolism

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  PMID 11452218
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The fourth Musketeer — from Alexandre Dumas to Claude Bernard

  2006cited by this paper
• Cardiovascular risk factors clustering with endogenous hyperinsulinaemia predict death from coronary heart disease in patients with Type II diabetes

  2000cited by this paper
• Rosiglitazone short-term monotherapy lowers fasting and post-prandial glucose in patients with Type II diabetes

  2000cited by this paper
• Hyperinsulinemia, hyperglycemia, and impaired hemostasis: the Framingham Offspring Study.

  2000cited by this paper
• Relationship between insulin resistance, soluble adhesion molecules, and mononuclear cell binding in healthy volunteers.

  1999cited by this paper
• Mononuclear cell adherence to cultured endothelium is enhanced by hypertension and insulin resistance in healthy nondiabetic volunteers.

  1999cited by this paper
• Fatty acid inhibition of glucose-stimulated insulin secretion is enhanced in pancreatic islets from insulin-resistant rats.

  1999cited by this paper
• Hyperinsulinemia in a normal population as a predictor of non-insulin-dependent diabetes mellitus, hypertension, and coronary heart disease: the Barilla factory revisited.

  1999cited by this paper
• Troglitazone monotherapy improves glycemic control in patients with type 2 diabetes mellitus: a randomized, controlled study. The Troglitazone Study Group.

  1998cited by this paper
• Metabolic Effects of Troglitazone Monotherapy in Type 2 Diabetes Mellitus

  1998cited by this paper
• Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.

  1998cited by this paper
• Resistance to insulin-mediated glucose disposal as a predictor of cardiovascular disease.

  1998cited by this paper
• Adherence of Mononuclear Cells to Endothelium In Vitro Is Increased in Patients With NIDDM

  1997cited by this paper
• Cholesterol Lowering With Simvastatin Improves Prognosis of Diabetic Patients With Coronary Heart Disease: A subgroup analysis of the Scandinavian Simvastatin Survival Study (4S)

  1997cited by this paper
• The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators.

  1996cited by this paper
• Pathophysiology of insulin resistance in human disease.

  1995cited by this paper
• Opposite effects of short- and long-term fatty acid infusion on insulin secretion in healthy subjects

  1995cited by this paper
• Effect of variations in dietary fat and carbohydrate intake on postprandial lipemia in patients with noninsulin dependent diabetes mellitus.

  1993cited by this paper
• Plasma insulin, C-peptide, and proinsulin concentrations in obese and nonobese individuals with varying degrees of glucose tolerance.

  1993cited by this paper
• LDL subclass phenotypes and triglyceride metabolism in non-insulin-dependent diabetes.

  1992cited by this paper
• Banting lecture 1988. Role of insulin resistance in human disease.

  1988cited by this paper
• Role of insulin in regulation of lipoprotein metabolism in diabetes.

  1988cited by this paper
• Measurement of Plasma Glucose, Free Fatty Acid, Lactate, and Insulin for 24 h in Patients With NIDDM

  1988cited by this paper
• High density lipoprotein (HDL) metabolism in noninsulin-dependent diabetes mellitus: measurement of HDL turnover using tritiated HDL.

  1987cited by this paper
• The pathogenesis of atherosclerosis--an update.

  1986cited by this paper
• Chronic hyperglycemia is associated with impaired glucose influence on insulin secretion. A study in normal rats using chronic in vivo glucose infusions.

  1986cited by this paper
• Moderate weight loss and sulfonylurea treatment of non-insulin-dependent diabetes mellitus. Combined effects.

  1985cited by this paper
• Effect of In Vivo Plasma Insulin Levels on the Relationship between Perfusate Free Fatty Acid Concentration and Triglyceride Secretion by Perfused Rat Livers

  1984cited by this paper
• Evidence for multiple causality in the development of diabetic hypertriglyceridaemia

  1980cited by this paper
• Insulin secretion improves following dietary control of plasma glucose in severely hyperglycemic obese patients.

  1980cited by this paper
• Diet-induced improvement of abnormalities in insulin and glucagon secretion and in insulin receptor binding in diabetes mellitus.

  1979cited by this paper

• The Assessment Metabolic Markers and Cardio Risk Index Among Controlled and Uncontrolled Type 2 Diabetic Patients in Primary Health Clinics in Medan City, North Sumatera, Indonesia: Cross-sectional Study

  2022cites this paper
• THE DEVELOPMENT OF ATHEROSCLEROSIS IN PATIENTS WITH DIABETES MELLITUS

  2020cites this paper
• Reduced expression of Twist 1 is protective against insulin resistance of adipocytes and involves mitochondrial dysfunction

  2018influential citation
• Type II diabetes mellitus and cardiovascular risk factors: Current therapeutic approaches.

  2007cites this paper
• Waist circumference is a better predictor than body mass index of coronary heart disease risk in overweight premenopausal women.

  2004cites this paper
• Upregulation of insulin receptor substrate-2 in pancreatic beta cells prevents diabetes.

  2003cites this paper